Hansen Medical Announces Exploration of Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/6/2026
- Stocks close lower as investors eye Mideast talks, earnings
- Trump held multiple undisclosed calls with Fed Chair Warsh, reports say
- Sandisk unveils underwhelming outlook despite AI demand surge; shares slip
- Alphabet taps bond market with sweeping 10-part offering to fuel AI ambitions
- Citi says buy the pullback in memory stocks as upcycle is still in early innings
- Salesforce president Srini Tallapragada steps down, becomes advisor
- EverCommerce names Alex Goor as new CEO, founder steps down
- Sandisk (SNDK) Tops Q4 EPS by $4.66, Offers Guidance
- Crude Inventory Rose 2.5 Million Barrels Last Week - EIA
- AMD shares slide 8% after Musk flags plans to buy Nvidia chips for SpaceX
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Hansen Medical (HNSN) Ticks Higher Upon Resumption
January 14, 2016 8:56 AM ESTHansen Medical (Nasdaq: HNSN) shares are up over 17 percent in premarket trading Thursday.
Earlier, HNSN announced plans to explore strategic alternatives.
... MoreHansen Medical (HNSN) Announces Expansion of Sensei, Magellan Utility and Regulatory Labeling
January 14, 2016 8:06 AM ESTHansen Medical, Inc. (NASDAQ: HNSN) will expand the utility and regulatory labeling of the Sensei and Magellan product lines:
ARTISAN IDE Study: This study is a prospective, single arm study of the Hansen Sensei System for introducing and positioning RF ablation catheters in subjects with paroxysmal atrial fibrillation (PAF). As of January 8, 2016: 148 subjects have been enrolled and treated, and 2 cases are pending to complete full enrollment of 150. In preparation for future commercialization, the initial PMA shell was submitted to FDA, paving the regulatory pathway. This clinical trial... More
